# NMI Holdings, Inc.: financial statements, quarterly

NMIH · Nasdaq · CIK 1547903 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nmih.md) · [Financials](/companies/nmih/financials.md) · [Filings](/companies/nmih/filings.md) · [Insiders](/companies/nmih/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nmih/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [148](/filings/0001547903-24-000159.md) | [151 d](/filings/0001547903-26-000011.md) | [156](/filings/0001547903-25-000060.md) | [162](/filings/0001547903-25-000094.md) | [166](/filings/0001547903-25-000103.md) | [167 d](/filings/0001547903-26-000011.md) | [173](/filings/0001547903-26-000029.md) | [174](/filings/0001547903-26-000038.md) | [179](/filings/0001547903-25-000103.md) | [181 d](/filings/0001547903-26-000011.md) | [183](/filings/0001547903-26-000029.md) | [188](/filings/0001547903-26-000038.md) |
| Interest expense | $m | [8.1](/filings/0001547903-24-000035.md) | [8.1](/filings/0001547903-24-000035.md) | [8.0](/filings/0001547903-24-000103.md) | [14.7](/filings/0001547903-25-000094.md) | [7.1](/filings/0001547903-25-000103.md) | [7.1 d](/filings/0001547903-26-000011.md) | [7.1](/filings/0001547903-26-000029.md) | [7.1](/filings/0001547903-26-000038.md) | [7.1](/filings/0001547903-25-000103.md) | [7.1 d](/filings/0001547903-26-000011.md) | [7.1](/filings/0001547903-26-000029.md) | [7.1](/filings/0001547903-26-000038.md) |
| Income tax | $m | [23.3](/filings/0001547903-24-000159.md) | [21.8](/filings/0001547903-24-000035.md) | [25.5](/filings/0001547903-25-000060.md) | [26.6](/filings/0001547903-25-000094.md) | [26.5](/filings/0001547903-25-000103.md) | [24.7 d](/filings/0001547903-26-000011.md) | [28.8](/filings/0001547903-26-000029.md) | [27.5](/filings/0001547903-26-000038.md) | [27.7](/filings/0001547903-25-000103.md) | [26.9 d](/filings/0001547903-26-000011.md) | [25.6](/filings/0001547903-26-000029.md) | [31.2](/filings/0001547903-26-000038.md) |
| Net income | $m | [84.0](/filings/0001547903-24-000159.md) | [83.4](/filings/0001547903-24-000035.md) | [89.1](/filings/0001547903-25-000103.md) | [92.1](/filings/0001547903-25-000103.md) | [92.8](/filings/0001547903-25-000103.md) | [86.2 d](/filings/0001547903-26-000011.md) | [103](/filings/0001547903-26-000038.md) | [96.2](/filings/0001547903-26-000038.md) | [96.0](/filings/0001547903-25-000103.md) | [94.2 d](/filings/0001547903-26-000011.md) | [99.3](/filings/0001547903-26-000038.md) | [106](/filings/0001547903-26-000038.md) |
| Diluted EPS | $ per share | [1.00](/filings/0001547903-24-000159.md) | [1.01](/filings/0001547903-24-000035.md) | [1.08](/filings/0001547903-25-000060.md) | [1.13](/filings/0001547903-25-000094.md) | [1.15](/filings/0001547903-25-000103.md) | not reported | [1.28](/filings/0001547903-26-000029.md) | [1.21](/filings/0001547903-26-000038.md) | [1.22](/filings/0001547903-25-000103.md) | not reported | [1.28](/filings/0001547903-26-000029.md) | [1.38](/filings/0001547903-26-000038.md) |
| Basic EPS | $ per share | [1.02](/filings/0001547903-24-000159.md) | [1.03](/filings/0001547903-24-000035.md) | [1.10](/filings/0001547903-25-000060.md) | [1.15](/filings/0001547903-25-000094.md) | [1.17](/filings/0001547903-25-000103.md) | not reported | [1.31](/filings/0001547903-26-000029.md) | [1.23](/filings/0001547903-26-000038.md) | [1.24](/filings/0001547903-25-000103.md) | not reported | [1.30](/filings/0001547903-26-000029.md) | [1.40](/filings/0001547903-26-000038.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [2,762](/filings/0001547903-23-000140.md) | [2,941](/filings/0001547903-25-000026.md) | [3,006](/filings/0001547903-24-000103.md) | [3,102](/filings/0001547903-24-000139.md) | [3,320](/filings/0001547903-24-000159.md) | [3,350](/filings/0001547903-26-000011.md) | [3,456](/filings/0001547903-25-000060.md) | [3,591](/filings/0001547903-25-000094.md) | [3,727](/filings/0001547903-25-000103.md) | [3,841](/filings/0001547903-26-000038.md) | [3,910](/filings/0001547903-26-000029.md) | [3,997](/filings/0001547903-26-000038.md) |
| Total liabilities | $m | [971](/filings/0001547903-23-000140.md) | [1,015](/filings/0001547903-25-000026.md) | [1,028](/filings/0001547903-24-000103.md) | [1,056](/filings/0001547903-24-000139.md) | [1,125](/filings/0001547903-24-000159.md) | [1,133](/filings/0001547903-26-000011.md) | [1,135](/filings/0001547903-25-000060.md) | [1,171](/filings/0001547903-25-000094.md) | [1,212](/filings/0001547903-25-000103.md) | [1,249](/filings/0001547903-26-000038.md) | [1,277](/filings/0001547903-26-000029.md) | [1,292](/filings/0001547903-26-000038.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,791](/filings/0001547903-24-000159.md) | [1,926](/filings/0001547903-26-000011.md) | [1,978](/filings/0001547903-25-000103.md) | [2,046](/filings/0001547903-25-000103.md) | [2,195](/filings/0001547903-25-000103.md) | [2,217](/filings/0001547903-26-000038.md) | [2,322](/filings/0001547903-26-000038.md) | [2,420](/filings/0001547903-26-000038.md) | [2,515](/filings/0001547903-25-000103.md) | [2,592](/filings/0001547903-26-000038.md) | [2,632](/filings/0001547903-26-000038.md) | [2,705](/filings/0001547903-26-000038.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [121 d](/filings/0001547903-24-000159.md) | [30.1 d](/filings/0001547903-26-000011.md) | [112](/filings/0001547903-25-000060.md) | [118 d](/filings/0001547903-25-000094.md) | [128 d](/filings/0001547903-25-000103.md) | [35.8 d](/filings/0001547903-26-000011.md) | [101](/filings/0001547903-26-000029.md) | [128 d](/filings/0001547903-26-000038.md) | [128 d](/filings/0001547903-25-000103.md) | [61.7 d](/filings/0001547903-26-000011.md) | [116](/filings/0001547903-26-000029.md) | [143 d](/filings/0001547903-26-000038.md) |
| Capital expenditure | $m | [3.3 d](/filings/0001547903-24-000159.md) | [1.5 d](/filings/0001547903-26-000011.md) | [2.2](/filings/0001547903-25-000060.md) | [1.8 d](/filings/0001547903-25-000094.md) | [1.5 d](/filings/0001547903-25-000103.md) | [1.4 d](/filings/0001547903-26-000011.md) | [1.7](/filings/0001547903-26-000029.md) | [1.6 d](/filings/0001547903-26-000038.md) | [1.8 d](/filings/0001547903-25-000103.md) | [1.6 d](/filings/0001547903-26-000011.md) | [1.1](/filings/0001547903-26-000029.md) | [2.4 d](/filings/0001547903-26-000038.md) |
| Share repurchases | $m | [19.3 d](/filings/0001547903-24-000159.md) | [31.6 d](/filings/0001547903-26-000011.md) | [25.2](/filings/0001547903-25-000060.md) | [26.8 d](/filings/0001547903-25-000094.md) | [16.9 d](/filings/0001547903-25-000103.md) | [28.7 d](/filings/0001547903-26-000011.md) | [25.9](/filings/0001547903-26-000029.md) | [24.0 d](/filings/0001547903-26-000038.md) | [24.6 d](/filings/0001547903-25-000103.md) | [30.6 d](/filings/0001547903-26-000011.md) | [27.7](/filings/0001547903-26-000029.md) | [32.3 d](/filings/0001547903-26-000038.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [84.8](/filings/0001547903-24-000103.md) | [84.2](/filings/0001547903-24-000139.md) | [83.7](/filings/0001547903-24-000159.md) | [82.7](/filings/0001547903-24-000035.md) | [82.1](/filings/0001547903-25-000060.md) | [81.3](/filings/0001547903-25-000094.md) | [81.0](/filings/0001547903-25-000103.md) | [79.9](/filings/0001547903-26-000029.md) | [79.3](/filings/0001547903-26-000038.md) | [78.8](/filings/0001547903-25-000103.md) | [77.4](/filings/0001547903-26-000029.md) | [76.6](/filings/0001547903-26-000038.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 75,217,851 at 2026-07-27, from the cover of the [10-Q filed 2026-07-31](/filings/0001547903-26-000038.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.